Free tool
Oncology stocks
We cover 27 companies grouped under the Oncology theme. The median market value in the group is $398.28M. Across the group, the median move over the past trading day is +0.08%. 50% of the 24 with a 200-day average trade above it. Price change over the past year runs from −45.9% to +222.9% across the middle 80 percent of the group, with a median of −2.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
27 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% | Oct 30, 2026 |
| 0J9P.L | Incyte Corporation | $129.02 | +1.10% | +29.30% | +53.49% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% | Nov 5, 2026 |
| 0IJO.L | Exelixis, Inc. | $56.81 | +4.53% | +31.50% | +50.53% | Oct 27, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% | Nov 12, 2026 |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% | Nov 12, 2026 |
| 0QAV.L | Nanobiotix S.A. | 35.02 EUR | −1.38% | +82.87% | +351.98% | Sep 29, 2026 |
| 0KCS.L | OPKO Health, Inc. | $1.49 | +0.68% | +14.66% | +5.64% | Oct 28, 2026 |
| 0IL8.L | Kyntra Bio, Inc. | $7.96 | +1.58% | −11.17% | −28.07% | Nov 9, 2026 |
| 0LOV.L | Verastem, Inc. | $7.15 | +3.62% | −1.79% | −19.93% | Nov 3, 2026 |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% | Aug 27, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $46.18 | −1.66% | +104.45% | +136.88% | Nov 5, 2026 |
| 0IV3.L | Geron Corporation | $1.53 | −0.97% | +15.53% | +7.77% | Nov 4, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% | Aug 27, 2026 |
| 0IMT.L | Photocure ASA | 53.80 NOK | +0.35% | −25.59% | −12.66% | Oct 28, 2026 |
| 0RU5.L | Oncoinvent ASA | 85.40 NOK | 0.00% | +96.77% | +7339.02% | Aug 27, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| 0J4V.L | Heron Therapeutics, Inc. | $0.31 | −3.55% | −76.14% | −78.12% | Nov 3, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | 3.19 EUR | −1.30% | −39.91% | −48.50% | Sep 28, 2026 |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% | Nov 25, 2026 |
| 0GP7.L | Medivir AB (publ) | 2.03 SEK | +6.77% | +345.66% | +1.60% | Nov 5, 2026 |
| 0HS8.L | Lisata Therapeutics, Inc. | $1.84 | +5.14% | −2.13% | −26.55% | Nov 5, 2026 |
| 0VQ.DE | PureTech Health plc | 1.35 EUR | 0.00% | −12.90% | +1.50% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.